AI-Designed Drug Shows Potential to Reverse Biological Aging Clocks in Early Trial
First seen · 9/8/2026, 12:34 AMLatest activity · 9/8/2026, 12:34 AM
In an early clinical trial published in Nature Biotechnology, Insilico Medicine's AI-designed drug rentosertib showed preliminary signs of reversing biological aging markers. Six independent epigenetic clocks estimated that treated patients were biologically up to six years younger than the placebo cohort. Although limited to 42 patients and not yet tested in healthy individuals, the trial offers rare human data on an algorithmic molecule altering physiological markers.
Event heat · last 24 hours
There are 7 persisted snapshots in the last 24 hours. Peak heat was 10 at 9/12, 17:00; latest heat is 10.